• Research and Development

  Esbriet Shown to be Safe and Effective to Manage IPF

  Posted by Pulmonary Fibrosis News Moderator on September 4, 2018 at 4:13 pm

  A retrospective analysis of data from three Phase 3 trials shows Esbriet is safe and effective to manage IPF despite dose reductions.

  Click here to learn more about these trial results.

  Did you know about these trials? What do you think about this news?

  replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply